Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by MrMonkon Aug 04, 2013 8:53pm
271 Views
Post# 21649557

Poop or get off the pot...

Poop or get off the pot...August 31st is the deadline date for yes/no on Phase 3.  I've heard that Hecla may try to renegotiate  the terms of deal.  There are several other parties interested in the property and the area.  Should be interesting.

Latest 43-101 was calculated with conservatism in mind.  New ounces were added but some were lost due to the greater degree of conservatism.  As a project moves closer to commercialization, greater conservatism is needed.  We should be more confident in the resource after the latest calculation.

NOX is in good shape on September 1st regardless of Hecla's decision.  Pricing of gold is starting to move back in the right direction.  We have the makings of a sustained move up in both gold and NOX.  Longs will come out on top.

-- MM
<< Previous
Bullboard Posts
Next >>